Tech & Pharma

Turning Waste Heat Into Air Conditioning Turning Waste Heat Into Air Conditioning
  • August 29th, 2014
  • The Combined Heat and Power plant jointly developed by A*STAR and Hitachi achieves high efficiency with low operation costs.

» Read More...

Tech & Pharma

Turning Waste Heat Into Air Conditioning

Turning Waste Heat Into Air Conditioning

The Combined Heat and Power plant jointly developed by A*STAR and Hitachi achieves high efficiency with low operation costs.

Eisai & Zeria To Develop Gastic Acid Drug

Eisai & Zeria To Develop Gastic Acid Drug

Eisai grants Zeria the right to manufacture E3710, a proton pump inhibitor than can be used to treat gastric acid-related diseases.

South Korean FDA Approval For Green Cross’ Neulapeg®

South Korean FDA Approval For Green Cross’ Neulapeg®

Green Cross receives regulatory approval for its once-per-cycle dose neutropenia drug, Neulapeg®.

Amerigen’s Mecobalamin Receives CFDA Approval

Amerigen’s Mecobalamin Receives CFDA Approval

The CFDA approval of Mecobalamin marks Amerigen’s entry into the Chinese generics market.

Hanmi Licenses Poziotinib To Luye Pharma

Hanmi Licenses Poziotinib To Luye Pharma

Luye acquires the rights to Poziotinib, Hanmi’s pan-HER inhibitor for the treatment of cancer.

ZAI Lab Licenses Respiratory Disease Drugs From Sanofi

ZAI Lab Licenses Respiratory Disease Drugs From Sanofi

ZAI Lab has acquired the license for two pre-clinical drugs for chronic respiratory diseases.

PW Medtech Acquires Tianxinfu For US$130 Million

PW Medtech Acquires Tianxinfu For US$130 Million

PW Medtech expands its capabilities in medical devices with the acquisition of Beijing Tianxinfu Medical Appliance Co.

Fosun Commits US$111 Million To Partnership With Public Hospital

Fosun Commits US$111 Million To Partnership With Public Hospital

The partnership between Fosun and Taizhou Muncipal Hospital will add approximately 2,000 new hospital beds to serve the residents of Taizhou.

Celltrion Files For FDA Approval For Biosimilar Drug

Celltrion Files For FDA Approval For Biosimilar Drug

Celltrion predicts that it is one year away from approval for Remsima®, a biosimilar based on an originator drug from Janssen Biotech.

Fujitsu & NCKU Sign Big Data Platform MOU

Fujitsu & NCKU Sign Big Data Platform MOU

The National Cheng Kung University and Fujitsu will develop a cloud computing platform for big data analysis in agriculture and genomics research.